5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy; D003967:Diarrhea / Q000139:chemically induced; D005069:Evaluation Studies as Topic; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage* / Q000009:adverse effects; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy*; D010689:Phlebitis / Q000139:chemically induced; D013280:Stomatitis / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D005472:Fluorouracil